ES2164235T3 - Derivados de piperazinona sustituidos por un heterociclo que actuan como antagonistas del receptor de taquiquinina. - Google Patents

Derivados de piperazinona sustituidos por un heterociclo que actuan como antagonistas del receptor de taquiquinina.

Info

Publication number
ES2164235T3
ES2164235T3 ES96905333T ES96905333T ES2164235T3 ES 2164235 T3 ES2164235 T3 ES 2164235T3 ES 96905333 T ES96905333 T ES 96905333T ES 96905333 T ES96905333 T ES 96905333T ES 2164235 T3 ES2164235 T3 ES 2164235T3
Authority
ES
Spain
Prior art keywords
piperazinona
antagonist
derivatives
receiver
taquiquinine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96905333T
Other languages
English (en)
Inventor
Timothy P Burkholder
Elizabeth M Kudlacz
Tieu-Binh Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2164235T3 publication Critical patent/ES2164235T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE DERIVADOS DE PIPERAZINONA SUSTITUIDOS DE FORMULA (I), LOS ESTEREOISOMEROS O LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, Y SU UTILIZACION COMO ANTAGONISTAS DEL RECEPTOR DE TAQUICININA. ESTOS ANTAGONISTAS RESULTAN UTILES EN EL TRATAMIENTO DE ENFERMEDADES Y TRASTORNOS MEDIADOS POR TAQUICININA DESCRITAS EN LA PRESENTE: ASMA, TOS Y BRONQUITIS. LA PRESENTE INVENCION TAMBIEN TRATA DE INTERMEDIOS UTILES EN LA PREPARACION DE COMPUESTOS DE FORMULA (I).
ES96905333T 1995-03-15 1996-02-06 Derivados de piperazinona sustituidos por un heterociclo que actuan como antagonistas del receptor de taquiquinina. Expired - Lifetime ES2164235T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40478895A 1995-03-15 1995-03-15

Publications (1)

Publication Number Publication Date
ES2164235T3 true ES2164235T3 (es) 2002-02-16

Family

ID=23601038

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96905333T Expired - Lifetime ES2164235T3 (es) 1995-03-15 1996-02-06 Derivados de piperazinona sustituidos por un heterociclo que actuan como antagonistas del receptor de taquiquinina.

Country Status (21)

Country Link
US (2) US5840726A (es)
EP (1) EP0815105B1 (es)
JP (1) JP3825472B2 (es)
KR (1) KR19980703032A (es)
CN (1) CN1067068C (es)
AR (1) AR002715A1 (es)
AT (1) ATE206421T1 (es)
AU (1) AU697599B2 (es)
CA (1) CA2215333C (es)
DE (1) DE69615670T2 (es)
DK (1) DK0815105T3 (es)
ES (1) ES2164235T3 (es)
FI (1) FI973671A0 (es)
HU (1) HUP9702149A3 (es)
IL (1) IL117453A (es)
NO (1) NO314693B1 (es)
NZ (1) NZ302948A (es)
PT (1) PT815105E (es)
TW (1) TW464647B (es)
WO (1) WO1996028441A1 (es)
ZA (1) ZA961954B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000502100A (ja) * 1995-12-18 2000-02-22 藤沢薬品工業株式会社 タキキニン拮抗薬としてのピペラジン誘導体
DE19939910A1 (de) * 1999-08-23 2001-03-01 Morphochem Ag Neue Verbindungen, die Tryptase-Aktivität hemmen
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
EP1670314A4 (en) * 2003-09-05 2009-02-25 Sequella Inc METHODS AND COMPOSITIONS INCLUDE DIAMINE AS A NEW THERAPEUTIC FOR TUBERCULOSIS
WO2009136965A1 (en) * 2008-05-06 2009-11-12 Sequella, Inc. Compositions and methods comprising capuramycin analogues

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3132882A1 (de) * 1981-08-20 1983-03-03 Cassella Ag, 6000 Frankfurt Neue piperazinone, ihre herstellung und verwendung
FI97540C (fi) * 1989-11-06 1997-01-10 Sanofi Sa Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1994003483A1 (en) * 1992-07-30 1994-02-17 Chiron Corporation Endothelin receptor-binding compounds
GB9222486D0 (en) * 1992-10-26 1992-12-09 Merck Sharp & Dohme Therapeutic agents
HU224496B1 (hu) * 1993-05-06 2005-10-28 Merrel Dow Pharmaceuticals Inc. Pirrolidin-3-il-alkil-piperidin-származékok és e vegyületeket tartalmazó gyógyászati készítmények
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
AR002715A1 (es) 1998-04-29
KR19980703032A (ko) 1998-09-05
AU697599B2 (en) 1998-10-08
NZ302948A (en) 2001-05-25
DE69615670T2 (de) 2002-08-08
CA2215333C (en) 2002-01-01
DK0815105T3 (da) 2002-01-21
CN1067068C (zh) 2001-06-13
US5864045A (en) 1999-01-26
ATE206421T1 (de) 2001-10-15
JP3825472B2 (ja) 2006-09-27
DE69615670D1 (de) 2001-11-08
HUP9702149A2 (hu) 1999-06-28
HUP9702149A3 (en) 1999-07-28
IL117453A0 (en) 1996-07-23
EP0815105B1 (en) 2001-10-04
TW464647B (en) 2001-11-21
NO974205L (no) 1997-11-13
ZA961954B (en) 1996-09-17
WO1996028441A1 (en) 1996-09-19
PT815105E (pt) 2002-03-28
US5840726A (en) 1998-11-24
FI973671A (fi) 1997-09-12
FI973671A0 (fi) 1997-09-12
JPH11501917A (ja) 1999-02-16
CA2215333A1 (en) 1996-09-19
AU4930696A (en) 1996-10-02
IL117453A (en) 2000-07-26
EP0815105A1 (en) 1998-01-07
NO974205D0 (no) 1997-09-12
CN1178529A (zh) 1998-04-08
MX9706872A (es) 1997-11-29
NO314693B1 (no) 2003-05-05

Similar Documents

Publication Publication Date Title
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
ES2134859T3 (es) Derivados de 4-carboxoamido-piperidina, productos intermedios y uso como antagonistas de neurokinina.
BR0112756A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
UY26839A1 (es) Productos de derivados de la 4 - fenil - piridina
DE60229530D1 (de) Substituierte piperazine als modulatoren des melanocortinrezeptors
ECSP034640A (es) Derivados de feniletenilo o feniletinilo como antagonistas del receptor del glutamato
EA200301142A1 (ru) Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6
ES2158814B1 (es) Derivados de pirrolidina antagonistas del receptor ccr-3
UY26782A1 (es) Derivados del benzotiazol
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
ES2168487T3 (es) Derivados de n-heteroaril-piridinasulfonamida y su uso como antagonistas de la endotelina.
BR0311494A (pt) Novos indóis substituìdos
ECSP067116A (es) Antagonistas del receptor 2 de citocina quimioatrayente de sales cuaternarias
EE200300324A (et) Asendatud alküülamiini derivaadid ja nende kasutamismeetodid
DE60334015D1 (de) Pyridopyrrolizin- und pyridoindolizinderivate
CY1106645T1 (el) Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος
ES2132223T3 (es) Derivados de indol condensados en calidad de antagonistas del receptor 5-ht4.
ECSP045156A (es) Derivados de indolilalquilamina como ligandos 5-hidroxitriptamina-6
ECSP045473A (es) Derivados de 1-(aminoalquil)-3-sulfonilindol y 1-aminoalquil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6
ATE399770T1 (de) Tachykininrezeptorantagonisten
ECSP066474A (es) Arilindenopiridinas y arilindenopirimidinas y su uso como antagonista del receptor adenosina a2a
ES2188344B1 (es) Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
PA8532201A1 (es) Derivados de fenil cetonas sustituidas como antagonistas de ip
ES2127524T3 (es) Derivados de benzamida como antagonistas de vasopresina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 815105

Country of ref document: ES